Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology.

BACKGROUND: Predicting survival of patients with spinal metastases would help stratify treatments from aggressive to palliation. OBJECTIVE: To evaluate whether sarcopenia predicts survival in patients with lung, breast, prostate, or multiple myeloma spinal metastases. METHODS: Psoas muscle measurements in patients with spinal metastasis were taken from computed tomography scans at 2 time points: at first episode of stereotactic body radiation therapy (SBRT) and from the most recent scan available. Overall survival and hazard ratios were calculated with multivariate cox proportional hazards regression analyses. RESULTS: In 417 patients with spinal metastases, 40% had lung cancer, 27% breast, 21% prostate, and 11% myeloma. Overall survival was not associated with age, sex, ethnicity, levels treated, or SBRT volume. Multivariate analysis showed patients in the lowest psoas tertile had shorter survival (222 d, 95% CI = 185-323 d) as compared to the largest tertile (579 d, 95% CI = 405-815 d), (HR1.54, P = .005). Median psoas size as a cutoff value was also strongly predictive for survival (HR1.48, P = .002). Survival was independent of tumor histology. The psoas/vertebral body ratio was also successful in predicting overall survival independent of tumor histology and gender (HR1.52, P < .01). Kaplan-Meier survival curves visually represent survival (P = .0005). CONCLUSION: In patients with spine metastases, psoas muscle size as a hallmark of frailty/sarcopenia is an objective, simple, and effective way to identify patients who are at risk for shorter survival, regardless of tumor histology. This information can be used to help with surgical decision making in patients with advanced cancer, as patients with small psoas sizes are at higher risk of death.

Mechanomyography for Intraoperative Assessment of Cortical Breach During Instrumented Spine Surgery.

OBJECTIVE: We sought to determine the utility of mechanomyography (MMG) in detecting and preventing pedicle breach in instrumented lumbar spine surgery. METHODS: In a prospective nonrandomized trial without controls, we selected consecutive patients to undergo intraoperative MMG during instrumented lumbar spine surgery. MMG testing was performed at the original pilot hole, after tapping, and after screw placement, with the minimum current to elicit a recorded MMG response. All patients underwent a postoperative computed tomography scan, and a single radiologist interpreted each pedicle to identify breach. Chi-square test was used to compare patients with and without breaches. Two sample Student's t-tests were used to compare changes in functional outcomes. Sensitivity and specificity of MMG were computed using receiver operating characteristic curve analysis. RESULTS: There were 122 consecutive instrumented lumbar surgery patients enrolled, with a total of 890 lumbar pedicle screws tested with MMG. The medial or inferior breach rate was 2.25%, with no statistically significant difference in Oswestry Disability Index or visual analog scale between patients who breached and who did not. For the MMG measurement from the original pilot hole, the area under the receiver operating characteristic was 0.835; the maximum combination of sensitivity (80.42%) and specificity (80.6%) was found using MMG current ≤12 mA. We found that an MMG cutoff of >12 mA resulted in a 99.5% likelihood of no medial or inferior breach. CONCLUSIONS: MMG can be safely used during instrumented lumbar spine surgery. A cutoff value of >12 mA for MMG can accurately predict and prevent medial and inferior pedicle screw breach.